Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ZS Pharma
Pharma
AZ puts kibosh on two studies of hyperkalemia med Lokelma
AstraZeneca has put the kibosh on two late-stage Lokelma trials testing the hyperkalemia drug in patients with heart and kidney diseases.
Fraiser Kansteiner
Dec 1, 2023 9:45am
AstraZeneca backs new hyperkalemia public awareness video series
Mar 6, 2023 9:24am
AZ finally wins hard-fought FDA nod for ZS-9, now dubbed Lokelma
May 21, 2018 11:10am
FDA document lays out issues undermining AZ's new drug
Apr 19, 2017 3:47pm
